Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy. [PDF]
Masri A +20 more
europepmc +1 more source
Amyloid fibril polymorphism in the heart and liver of a patient with polyneuropathic ATTRv-V122Δ amyloidosis. [PDF]
Ahmed Y +16 more
europepmc +1 more source
Efficacy and Safety of Acoramidis in Japanese Adults With Symptomatic Transthyretin Amyloid Cardiomyopathy. [PDF]
Endo J +17 more
europepmc +1 more source
Fully Automated vs. Human Echocardiogram Interpretation in Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study. [PDF]
McMenamin KJ +13 more
europepmc +1 more source
Therapy of Transthyretin Cardiomyopathy
openaire +2 more sources
Correlation between neuropathy severity and neurofilament light chain levels in Brazilian patients with hereditary transthyretin amyloidosis. [PDF]
Ferreira P +6 more
europepmc +1 more source
Don't raise your white flag facing a sea of red ones: when cardiac amyloidosis mimics hypertrophic cardiomyopathy. [PDF]
Grilli G +11 more
europepmc +1 more source
Multiple Red Flags of Transthyretin Amyloid Cardiomyopathy in a Single Patient: A Case Report on Diagnostic Challenge. [PDF]
Yao L, Chen K, Zhang F, Qin J.
europepmc +1 more source
Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE. [PDF]
Nativi-Nicolau J +12 more
europepmc +1 more source

